Lyophilized research peptides for in-vitro investigation.

Single-sequence and combination peptides supplied as sterile lyophilized powder in clear glass vials. Each lot is characterized by reversed-phase HPLC and ESI mass spectrometry.

10 compounds in this form

180 mg

GHK-Cu Vials

3 × 60 mg hermetically sealed sterile glass vials containing a pure, stable, self-assembling copper complex — naturally occurring copper complexed to the tripeptide GHK-Cu (Gly-His-Lys). Bio-identical.

30 mg

Retatrutide Vials

Retatrutide is a novel investigational peptide designed to target and activate multiple metabolic pathways.

60 mg

GHK-Cu Pen

60 mg/pen lyophilized GHK-Cu (Copper Peptide) — pre-filled multi-dose delivery device for subcutaneous use.

30 mg

Retatrutide Pen

30 mg/pen lyophilized Retatrutide — pre-filled multi-dose delivery device for subcutaneous use.

30 mg

BPC-157 Pen

30 mg/pen BPC-157 — pre-filled multi-dose delivery device for subcutaneous use.

100 IU

HGH (Somatropin) Pen

100 IU/pen lyophilized HGH (Somatropin) — pre-filled multi-dose delivery device for subcutaneous use.

10 mg

Tesamorelin Pen

10 mg/pen Tesamorelin — pre-filled multi-dose delivery device for subcutaneous use.

1500 mg

Glutathione Pen

1500 mg / 3 mL (500 mg/mL) Glutathione — pre-filled multi-dose delivery device for subcutaneous use. ≥ 98% purity.

25 mg

5-Amino-1MQ Pen

25 mg / 3 mL (8.33 mg/mL) 5-Amino-1MQ — pre-filled multi-dose delivery device for subcutaneous use. ≥ 98% purity.

500 mg

NAD+ Pen

500 mg / 3 mL (166.67 mg/mL) NAD+ — pre-filled multi-dose delivery device for subcutaneous use. ≥ 98% purity.

Other forms

Vials

Multi-dose glass vials of injectable research solutions.

Ampoules

Sealed single-use ampoules for high-precision dosing.

Tablets

Pressed tablets and blister-packaged compounds.

SARMs

Selective receptor-modulator reference compounds.